Von Der Leyen: Pfizer to Boost Q2 EU Vaccine Supply by 50M

The transcript discusses the challenges in vaccine delivery and the importance of swift action to support Europe's vaccination rollout. An agreement with Biotech Pfizer has been reached to accelerate the delivery of 50 million additional doses, initially planned for the fourth quarter of 2021, now available in the second quarter. This will bring the total to 250 million doses, distributed among Member States, aiding the vaccination campaigns.

What is the significance of the agreement reached with Biotech Pfizer?

How many additional doses of biotech Pfizer vaccines will be delivered in the second quarter?

What was the initial plan for the delivery of the 50 million doses?

What will be the total number of doses delivered by biotech Pfizer in the second quarter?

How will the additional 50 million doses be distributed among Member States?